A Case of Endogenous Klebsiella Endophthalmitis Associated with Acute Urinary Tract Infection, Cellulitis in a Type 2 Diabetic Patient

2010 ◽  
Vol 11 (3) ◽  
pp. 239
Author(s):  
Chi Sung Hwang ◽  
Ji Hye Suk ◽  
Ji Hyun Kang ◽  
Hyuk Yong Kwon ◽  
Hyeon Jin Kim ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Diabetic Patient ◽  
Type 2 Diabetic ◽  
Acute Urinary Tract Infection

scholarly journals The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis

2020 ◽  
Author(s):  
Aliakbar Vaisi-Raygani ◽  
Nader Salari ◽  
Mohammad mahdi Karami ◽  
Shadi Bokaee ◽  
Masoud Mohammadi ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Urinary Tract Infections ◽  
Meta Analysis ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Tract Infections ◽  
Type 2 Diabetic

Abstract Background Urinary tract infection is the most common infection in type 2 diabetic patients. Various studies have reported different outbreaks of urinary tract infections in type 2 diabetic patients, Therefore, the present study aimed to determine the prevalence of urinary tract infections in type 2 diabetic patients during a systematic review and meta-analysis to open windows to more detailed programs to reduce the incidence of urinary tract infections in type 2 diabetic patients. Methods In this study, systematic review and Meta-Analysis of study data related to the prevalence of urinary tract infection in type 2 diabetic patients using keywords including: Type 2 diabetes, urinary tract infection, diabetes, prevalence, Meta-Analysis and their English equivalents in SID, MagIran, IranMedex, IranDoc, Google scholar, Cochrane, Embase, Science Direct, Scopus, PubMed and Web of Science (ISI) databases over the years It was mined from 1993 to 2020.In order to perform the analysis of qualified studies, the model of random effects was used and the inconsistency of studies with I2 index was investigated. Data analysis was performed with Comprehensive Meta-Analysis (version 2). Results In a study of 15 studies with a sample size of 827,948 in Meta-Analysis, the overall prevalence of urinary tract infection in patients with type 2 diabetes was 11.5% (95% confidence interval: 7.8–16.7%). Increasing the number of years of research, the prevalence of urinary tract infections in diabetic patients of the Iranian type increased (P = 0.000), and with increasing age of participants (P = 0.000) and also with increasing sample size (P = 0.000), this prevalence decreased. Conclusion The results of this study show that urinary tract infections are highly prevalent in patients with type 2 diabetes, so due to the growing prevalence of diabetes and its complications such as urinary tract infections, the need for appropriate screening programs and health care policies is becoming more apparent.

scholarly journals Fungal urinary tract infection in outpatient practice: approaches to diagnosis and treatment

2022 ◽  
pp. 138-142
Author(s):  
N. V. Sturov ◽  
S. V. Popov ◽  
I. Yu. Shmelkov
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Urinary Tract Infection ◽  
Type 2 Diabetes Mellitus ◽  
Candida Albicans ◽  
Urinary Tract ◽  
Tract Infection ◽  
Diagnosis And Treatment ◽  
Days Of Therapy

Introduction. In recent years, the role of fungal infection in inpatient and outpatient patients has been increasing. At the same time, there are currently no recommendations on the duration of treatment of outpatient patients with fungal urinary tract infection (UTI). Aim of the study. Optimization of methods of diagnosis and treatment of outpatient patients with fungal UTI.Materials and methods. To detect fungi in urine, the E. Koneman et al. (1997) method was improved. 56 patients with fungal UTI were examined. The efficacy of fluconazole in the treatment of fungal UTI was studied in 53 patients.Results. Candida albicans was detected in 37% of cases of fungal UTI in outpatient patients. Risk factors for fungal UTI in outpatient patients include: antibacterial therapy, infravesical obstruction, type 2 diabetes mellitus and the presence of urinary drainage. The microbiological efficacy of fluconazole therapy for 7, 10 and 14 days was 83.0%, 94.3% and 96.2%, respectively. The growth of fungi in the urine a month after treatment was absent in 86.7% of patients. In outpatient patients with fungal UTI without type 2 diabetes mellitus, the efficacy of fluconazole at a dose of 150 mg per day for 7 days was 94.9%. In patients with type 2 diabetes mellitus after 7 days of therapy, the efficacy was 50.0%.Conclusions. The most common causative agent of fungal UTI in outpatient patients is Candida albicans. To detect fungi in urine, samples should be seeded on selective media, while increasing the seeding volume to 0.1 ml and extending the incubation time to 96 hours. Fluconazole is a highly effective treatment for fungal UTI at a dose of 150 mg per day for 7 days, however, in patients with diabetes mellitus, therapy should last at least 10 days.

scholarly journals Recurrent and complicated urinary tract infection in type 2 diabetes: Case series

2021 ◽  
Vol 12 (2) ◽  
pp. 228
Author(s):  
AmbikaGopalakrishnan Unnikrishnan ◽  
RahulR Kotalwar ◽  
GaurishM Karande ◽  
VedavatiB Purandare ◽  
HrishikeshS Deshmukh ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Case Series ◽  
Complicated Urinary Tract Infection ◽  
Diabetes Case

Trimethoprim in acute urinary tract infection

1980 ◽  
Vol 18 (13) ◽  
pp. 51-52
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Acute Urinary Tract Infection

Trimethoprim (Trimopan - Berk; Ipral - Squibb; Syraprim - Wellcome) is now marketed here for the prophylaxis and treatment of urinary tract infection. Hitherto it has only been available either combined with sulphamethoxazole as co-trimoxazole (Septrin; Bactrim), which is particularly well established in the treatment of urinary tract infection, or with sulphadiazine as co-trimazine (Coptin), a combination we reviewed recently.1 Trimethoprim has been available alone in Finland since 1973.

Sign in / Sign up

Export Citation Format

Share Document